INIS
rats
100%
drugs
76%
patients
74%
comparative evaluations
61%
doses
58%
evaluation
46%
learning
41%
control
38%
pharmacology
37%
india
32%
males
28%
hospitals
26%
levels
26%
nervous system diseases
24%
ulcers
23%
data
21%
animals
20%
hypertension
20%
mice
20%
teaching
19%
toxicity
18%
reviews
18%
diuretics
17%
hiv
17%
diseases
15%
clinical trials
15%
weight
15%
performance
13%
safety
13%
risks
13%
assessments
13%
blood
13%
people
12%
reduction
12%
diabetes mellitus
11%
lectures
11%
streptozotocin
11%
malaria
11%
titration
11%
honey
11%
liver
11%
cholesterol
11%
intake
10%
fruits
9%
lipids
9%
gum acacia
9%
cost
9%
glucose
9%
inflammation
9%
feedback
9%
Pharmacology, Toxicology and Pharmaceutical Science
Wistar Rat
65%
Diabetes Mellitus
33%
Resveratrol
23%
Alzheimer's Disease
23%
Donepezil
17%
Tribulus terrestris
17%
Vanillin
17%
Diuretic Activity
17%
Cyclorphan
17%
HIV
17%
Gum Arabic
14%
Antiinfective Agent
14%
Antidiabetic Agent
13%
Prevalence
13%
Clinical Trial
12%
Creatinine
12%
Streptozotocin
11%
Glibenclamide
11%
Non-Steroidal Anti-Inflammatory Drug
11%
Hyperlipidemia
11%
Bacopa monnieri
11%
Adverse Event
11%
Malignant Neoplasm
11%
Diuretic Agent
9%
Prospective Study
9%
Disease
8%
Cheilocostus speciosus
8%
Isotopes of Potassium
8%
Superoxide Dismutase
8%
Ulcer
7%
Dihydrotachysterol
7%
Albino Mouse
7%
Cognitive Defect
7%
Liver Injury
6%
Hepatotoxicity
6%
Analgesic Agent
6%
Adverse Drug Reaction
6%
Colchicine
6%
Amyloid Plaque
6%
Neurofibrillary Tangle
6%
Triacylglycerol
6%
Neuroprotective Agent
6%
Syzygium cumini
5%
Chemotherapy
5%
Thioacetamide
5%
Behavioral Toxicity
5%
Clinical Pharmacology
5%
Haloperidol-Induced Catalepsy
5%
Povidone-Iodine
5%
Rat Model
5%
Medicine and Dentistry
Tertiary Care
19%
Diabetes Mellitus
14%
Diabetic Foot Ulcer
11%
Geriatrics
11%
Nonsteroid Antiinflammatory Agent
11%
Human Immunodeficiency Virus
10%
Adverse Event
8%
Ulcer
7%
Clinical Trial
7%
Maturity Onset Diabetes of the Young
6%
Orthopedics
6%
Outpatient
6%
Health Literacy
5%
Medical Student
5%
Diuretic Activity
5%
Human Immunodeficiency Virus Infection
5%
Pharmacogenomics
5%
Povidone Iodine
5%
Personalized Medicine
5%
Molecular Marker
5%
Controlled Clinical Trial
5%
Clinical Study
5%
Chloroquine
5%
Modafinil
5%
Drug Dose Titration
5%
Tocilizumab
5%
Antimalarial Agent
5%
Osteoarthritis
5%
Radiation Therapy
5%
Antidiabetic Agent
5%
Pyridoxine
5%
Physiotherapy
5%
Pancreatitis
5%
Drug Resistance
5%
Gum Arabic
5%
Analgesic Activity
5%
Resveratrol
5%
Alzheimer's Disease
5%
Neuroprotective Agent
5%
Malignant Neoplasm
5%
Neuropathy
5%